The effect of pomegranate juice powder on diabetic nephropathy
Phase 2
- Conditions
- ephropathy caused by diabetes type 2.Diabetes mellitus With renal complications Diabetic nephropathy (N08.3*)E10-E14
- Registration Number
- IRCT2015121725574N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
inclusion criteria: patients 20 to 75 years old receiving reducer blood glucose drug and dietary recommendations for at least 6 month with type II diabetes. That the urine microalbumin and the amount of protein in urine 24 hours higher than normal and receive a fixed dose of either or both ACEI or ARB at least 3 months. Exclusion criteria: certain underlying diseases such as autoimmune diseases or cancer, allergies to plants used in the clinical trial, pregnancy and breastfeeding, dialysis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The 24-hour urine protein excretion. Timepoint: Before the intervention, one month after the intervention and after the end of the intervention. Method of measurement: 24-hour urine test.;Urine microalbumin excretion. Timepoint: Before the intervention, one month after the intervention and after the end of the intervention. Method of measurement: urine test.
- Secondary Outcome Measures
Name Time Method Serum BUN. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;Serum Creatinine. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;Fasting Blood Sugar. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;BMI. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;GFR. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;HDL. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;LDL. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;Cholesterol. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.;TG. Timepoint: The beginning and end of the intervention. Method of measurement: blood tests.